EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Importance of retesting SARS-CoV-2 borderline-positive samples in COVID 19 diagnostics

Hristina Gospodinović, Edita Grego, Milica Ivanović, Tamara Lukić, Jovana Ivanović, Nataša Simić, Danica Ćoćić, Maja Čabrilo, Verica Jovanović, Sofija Jovanović

Glasnik javnog zdravlja · 2022

DOI: 10.5937/serbjph2201018g ↗
AbstractBibliografische Angaben

Abstract

Numerous commercial tests for SARS-CoV-2 detection have been developed in response to the current COVID-19 pandemic. Our laboratory uses tests from two manufacturers, 2019-nCoV from Sansure and Xpert Xpress SARS-CoV-2 test from Cepheid. Protocols of different manufacturers list different predefined Ct (cycle threshold) values as cut-offs for a positive test. In this study, we focus on additional verification of Ct values for borderline positive samples, to confirm the results obtained. From May to November 2021, 88,708 tests were performed, of which 7,669 were positive and 224 were borderline positive. In retested borderline positive samples, positive results were obtained in 72.3% of the cases. Percentage of negative results upon retesting was 27.7%, which is almost a third of the total number of samples analysed. Based on these results, we can conclude that special attention must be paid when interpreting borderline positive results of RT-PCR tests. In the retesting process, if possible, it is particularly important to use a test with different properties.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →